Patterns of combined prescriptions of aspirin–Ginkgo biloba in Taiwan: a population‐based study

  title={Patterns of combined prescriptions of aspirin–Ginkgo biloba in Taiwan: a population‐based study},
  author={L.‐C. Chang and Nicole Huang and Y-J Chou and Feng-yu Kao and P. C. Hsieh and Y.‐T. Huang},
  journal={Journal of Clinical Pharmacy and Therapeutics},
Background and objectives:  Although interactions between aspirin and Ginkgo biloba extract (GBE) have been documented, the extent to which these two drugs are used in combination remains unclear. The aim of this study was to estimate the extent and utilization patterns of combined prescriptions of aspirin and GBE in Taiwan based on an analysis of a nationwide database. 
Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
Zhi-Gan-Cao-Tang and Dan Shen are the most commonly prescribed CHPs for IHD in Taiwan, and these results should be taken into account by physicians when devising individualized therapy for I HD. Expand
The association between low‐dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study
Considerable evidence suggests that aspirin has a chemopreventive effect on colorectal cancer (CRC). However, optimal dose and treatment duration have not been defined, and data on the effects ofExpand
A systematic review and meta-analysis of randomized controlled clinical trials of Ginkgo leaf extract and dipyridamole injection combined with aspirin for the treatment of cerebral infarction
Since 2009, a novel method, combining Ginkgo leaf extract and dipyridamole injections (Ginkgodipyridamole injection) with aspirin, has been widely used in China for the clinical treatment of cerebralExpand
Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005
This work has shown clear trends in the incidence of uncomplicated peptic ulcer and the trends in factors affecting its incidence, and these trends are likely to continue to change over time. Expand
Risk assessment and aspirin use in Asian and Western populations
Based on the current evidence, aspirin should be used for CVD prevention when the risk:benefit ratio is favorable and very low aspirin doses and even the wider use of gastroprotective agents may be the optimal approach to high-risk patients in Asia. Expand
Physicians' Attitudes toward Post-MI Aspirin Prophylaxis: Findings from an Online Questionnaire in Asia-Pacific
Abstract Mortality from cardiovascular diseases, such as myocardial infarction (MI), is predicted to increase dramatically in Asia-Pacific countries. However, there are few studies that estimateExpand
The combined effects of ginkgo biloba extracts and aspirin on viability of sk-N-mc, neuroblastoma cell line in hypoxia and reperfusion condition.
This study suggests that the combined treatments of Ginkgo biloba extracts and aspirin increase the regeneration of neuroblastoma cells injured by hypoxia and reperfusion. Expand
[Inhibition of sciadopitysin against UDP-glucuronosyltransferases].
The results demonstrated that the strong inhibition of sciadopitysin on UGT1A1 led to reduction of the metabolism of UGT2A1 substrates, and increased the risk of DDI, when co-administrated with other drugs. Expand


Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication.
We describe a case of persistent postoperative bleeding following total hip arthroplasty in which, initially, no obvious cause was identified. The patient was taking ginkgo biloba extract, anExpand
Herb-drug interactions
Patients should caution patients against mixing herbs and pharmaceutical drugs, as many reports of herb-drug interactions are sketchy and lack laboratory analysis of suspect preparations. Expand
Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers
  • S. Köhler, P. Funk, M. Kieser
  • Medicine
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • 2004
The study did not reveal any evidence to substantiate a causal relationship between the administration of EGb 761 and hemorrhagic complications, and there were no interpretable differences between EGb 661 and placebo except for a slight increase of gastrointestinal complaints during administration of the herbal extract. Expand
Clinical risk management of herb-drug interactions.
  • P. D. de Smet
  • Medicine
  • British journal of clinical pharmacology
  • 2007
Which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions are reviewed. Expand
Ginkgo biloba for tinnitus: a review.
A systematic review was aimed at summarising all randomised controlled trials on this subject and concluded that the regular medication with ginkgo biloba is effective in the treatment of tinnitus. Expand
Complementary medicine is booming worldwide
There are wide variations among countries in the degree of legal recognition such treatments enjoy and the ways in which they are practised, and the Treaty on European Union guarantees free access to such treatments. Expand
Herbs as medicines.
This review attempts to answer questions by investigating pertinent definitions, the history of herbs in medicine, epidemiology and prevalence of herbal use, and relevant psychosocial issues. Expand
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction.
Interaction between herbal medicine and cardiovascular drugs is a potentially important safety issue and patients taking anticoagulants are at the highest risk. Expand
Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.
It is suggested that Ginkgo biloba extract is superior to placebo in the symptomatic treatment of intermittent claudication, however, the size of the overall treatment effect is modest and of uncertain clinical relevance. Expand
Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.
Coadministration of G. biloba either with cilostazol or clopidogrel did not enhance antiplatelet activity compared with individual agents, and Ginkgo biloba potentiated the bleeding time prolongation effect of cilstazol. Expand